Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Overweight 1Osteoradionecrosis 1Obesity 1Neoplasms 1Mouth Neoplasms 1Metastasising Cancer of Unknown Primary 1Invasive Breast Cancer 1Endometrial Neoplasms 1Endometrial Hyperplasia 1Digestive System Neuroendocrine Tumor G1 1Coronary Artery Disease 1Colorectal Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 1Magnetic Resonance Spectroscopy 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Castration Resistant Prostate Cancer × Magnetic Resonance Spectroscopy × Clear all
NCT05919329 2025-10-24

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

OHSU Knight Cancer Institute

Phase 4 Recruiting
80 enrolled
Genitourinary

Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡